Latest filing published 16 Jul 2021 for Zymeworks Inc., €14k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Ali Tehrani in Zymeworks Inc. We count 8 filings; the first trade dates from 29 March 2019 and the latest from 15 July 2021.
Both buying and selling appear: 2 purchases worth €18k, against 3 sales worth €200k. On balance, insiders were net sellers of €182k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 option exercises.
The newest entry dates from 16 July 2021: an option exercise of €14k, in Zymeworks Inc. The latest purchase dates back some time: it was published 2,388 days ago, on 7 April 2020. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations